Wire Stories
-
435eCloudvalley Demonstrates its Cloud Expertise at CIO Innovation Forum
HONG KONG–(BUSINESS WIRE)–eCloudvalley Digital Technology (ECV), AWS Premier Tier Services Partner, has assisted more than 450 Hong Kong enterprises in digital transformation...
-
462Standard Chartered completes industry-first pilot of Trade Financing Validation Service provided by MonetaGo over SWIFT
SINGAPORE–(BUSINESS WIRE)–Standard Chartered has successfully completed an industry-first pilot testing of the Trade Financing Validation Service provided by MonetaGo over SWIFT, to...
-
52624 Tech Startups from Asian Countries & Regions to Compete for the 11th AEA 2022 Innovation Award
AEA 2022: October 26th (Wed.) to 27th (Thu.) Online Social Business Session Based on Dr. Muhammad Yunus� Seven Principles is also being...
-
500The Asahi Glass Foundation: Survey on the Awareness of Environmental Issues Among the General Public (in Japan and 24 other countries)
Climate change was rated as the top issue TOKYO–(BUSINESS WIRE)–The Asahi Glass Foundation, chaired by Takuya Shimamura, conducted an online survey of...
-
570The Asahi Glass Foundation Announces the Results of the 31st Annual �Questionnaire on Environmental Problems and the Survival of Humankind�
The time on the Clock has turned back for two consecutive years since 2021, striking 9:35 in 2022. It was the first...
-
538idolplus, Media Platform for K-pop Entertainers, Launched Globally in Six Languages
idolplus, a Korean media platform for K-pop entertainers, launched globally This web service released in six languages, including English, Chinese and Japanese,...
-
553Genexine�s First-in-Class Therapeutic DNA Vaccine Shows Significant Potential to Extend Survival in Late-Stage Cervical Cancer
Late-Breaking presentation of phase 2 results from a clinical trial of GX-188E in combination with KEYTRUDA�(pembrolizumab) demonstrates anti-tumor benefit in heavily pre-treated,...
-
452BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$bgne #beigene—BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing...
-
464Dave & Buster�s Reports Second Quarter 2022 Financial Results
DALLAS, Sept. 07, 2022 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an owner and...
-
627NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer
Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled in Asia...
